Anandamide transport: a critical review

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Anandamide (AEA) uptake has been proposed to occur via facilitated diffusion, but no specific protein transporter has been identified.
• Recent studies suggest AEA may passively diffuse across the plasma membrane, challenging the protein-mediated transport hypothesis.
• Conflicting kinetic data exists regarding the presence and nature of an AEA transporter.

Purpose of the Study:

• To analyze current literature on AEA uptake mechanisms.
• To explain the discrepancies in experimental findings regarding AEA transport.
• To discuss factors influencing AEA uptake studies, including incubation time, intracellular interactions, non-specific binding, and assay protocols.

Main Methods:

• Review and analysis of existing kinetic studies on AEA uptake under varying experimental conditions.
• Examination of the impact of incubation time on AEA uptake kinetics and observed interactions.
• Evaluation of factors such as non-specific binding to culture dishes, use of BSA, and development of novel transport inhibitors.

Main Results:

• Initial uptake kinetics (<1 min) are crucial for studying plasma membrane events and transporter saturability.
• Longer incubation times reveal intracellular interactions and potential receptor-mediated effects.
• Non-specific binding to plastic and variability in assay conditions (e.g., BSA use) complicate AEA transport studies.

Conclusions:

• Divergent views on AEA uptake mechanisms stem from variations in experimental methodologies, particularly incubation times and handling of non-specific binding.
• Development of specific inhibitors and characterization in FAAH knockout models are advancing the identification of AEA transport proteins.
• Further research is needed to definitively elucidate the protein-mediated or passive nature of AEA transport.